RS134-49

RS134-49
	File:RS134-49 structure.png
識別資訊
	IUPAC命名法 4-methyl-3-(1,2,3,6-tetrahydropyridin-5-yl)-1H-indole; ;
PubChem CID	168941768;
E編碼	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Module:EditAtWikidata第29行Lua錯誤：attempt to index field 'wikibase' (a nil value);
ECHA InfoCard	{{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤：attempt to index field 'wikibase' (a nil value)
化學資訊
化學式	C14H16N2
摩爾質量	212.30 g·mol−1
3D模型（JSmol）	交互式圖像;
	SMILES CC1=C2C(=CC=C1)NC=C2C3=CCCNC3;
	InChI InChI=1S/C14H16N2/c1-10-4-2-6-13-14(10)12(9-16-13)11-5-3-7-15-8-11/h2,4-6,9,15-16H,3,7-8H2,1H3; Key:UIZDBLDTIJHWHC-UHFFFAOYSA-N;

RS134-49是一種含氮有機化合物，分子式C₁₄H₁₆N₂，屬於色胺衍生物，帶有四氫吡啶環，可作為迷幻藥物。^[1]^[2]

參考文獻[編輯]

^ Kargbo RB. Small-Molecule Heterocyclic Compounds: Gq-Biased Agonists for the 5-HT2A Receptor in Neuropsychiatric Treatment. ACS Medicinal Chemistry Letters. November 2023, 14 (11): 1498–1500. PMC 10641896 可免費查閱. PMID 37974947. doi:10.1021/acsmedchemlett.3c00444. 已忽略未知參數|pmc-embargo-date= (幫助)
^ WO 2023114472,Manish J, Slocum S, Skiniotis G, Barros X, Jin J, Kaniskan HU, Sun N, Xiong Y, Shen Y, Xu Z, Qui X, Qian C, Song X, Deng Z, Roth B, Biberto J, Kuglae K, Suomivuori CM, Daemgen MA, Dror R, Shoichet B, Kaplan AL,「Heterocyclic compounds as 5ht2a biased agonists.」,發表於22 June 2023 （頁面存檔備份，存於互聯網檔案館）

識別資訊
File:RS134-49 structure.png
IUPAC命名法 4-methyl-3-(1,2,3,6-tetrahydropyridin-5-yl)-1H-indole
PubChem CID	168941768
E編碼	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Module:EditAtWikidata第29行Lua錯誤：attempt to index field 'wikibase' (a nil value)
ECHA InfoCard	{{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤：attempt to index field 'wikibase' (a nil value)
化學資訊
化學式	C₁₄H₁₆N₂
摩爾質量	212.30 g·mol⁻¹
3D模型（JSmol）	交互式圖像
SMILES CC1=C2C(=CC=C1)NC=C2C3=CCCNC3
InChI InChI=1S/C14H16N2/c1-10-4-2-6-13-14(10)12(9-16-13)11-5-3-7-15-8-11/h2,4-6,9,15-16H,3,7-8H2,1H3 Key:UIZDBLDTIJHWHC-UHFFFAOYSA-N